Obesity, which affects 650 million people worldwide, influences the development of cardiometabolic diseases and increases the risk of cancer.
Potential dangers of direct-to-consumer genetic test for cancer risk
A new editorial was published in Oncotarget’s Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition tests.”